Mangoceuticals, INC. (MGRX) SEC Filings — 2024
36 SEC filings for Mangoceuticals, INC. (MGRX) in 2024.
Filings
- MANGOCEUTICALS, INC. Files 8-K: Material Agreement & Equity Sales — 8-K · Dec 26, 2024
- MANGOCEUTICALS, INC. Completes Asset Acquisition, Discloses Equity Sales — 8-K · Dec 19, 2024
- MANGOCEUTICALS, INC. Files 8-K: Material Agreement, Equity Sales — 8-K · Dec 6, 2024
- Mangoceuticals Files Q3 2024 10-Q — 10-Q · Nov 14, 2024
- Mangoceuticals Adds Director, Discloses Officer Compensation — 8-K · Nov 12, 2024
- MANGOCEUTICALS, INC. Files 8-K Report — 8-K · Oct 31, 2024
- MANGOCEUTICALS, INC. Reports Unregistered Equity Sale — 8-K · Oct 25, 2024
- MANGOCEUTICALS, INC. Enters Material Definitive Agreement — 8-K · Oct 22, 2024
- MANGOCEUTICALS, INC. Files 8-K Report — 8-K · Oct 21, 2024
- MANGOCEUTICALS, INC. Files 8-K on Security Holder Rights — 8-K · Oct 11, 2024
- MANGOCEUTICALS, INC. Files 8-K Report — 8-K · Oct 3, 2024
- MANGOCEUTICALS, INC. Reports Unregistered Equity Sales — 8-K · Oct 2, 2024
- MANGOCEUTICALS, INC. Files 8-K Report — 8-K · Oct 1, 2024
- Mangoceuticals Reports Unregistered Equity Sale — 8-K · Sep 27, 2024
- Cohen Amends MANGOCEUTICALS Stake Filing — SC 13D/A · Aug 27, 2024
- MANGOCEUTICALS, INC. Reports Equity Sale and Officer Changes — 8-K · Aug 23, 2024
- Mangoceuticals Files S-1, Details Preferred Stock — S-1 · Aug 16, 2024
- MANGOCEUTICALS, INC. Files 8-K on Financials — 8-K · Aug 15, 2024
- Mangoceuticals Files Q2 2024 10-Q — 10-Q · Aug 14, 2024
- MANGOCEUTICALS, INC. Files 8-K: Material Agreement & Financials — 8-K · Jul 11, 2024
- MANGOCEUTICALS, INC. Files 8-K with Key Corporate Actions — 8-K · Jul 2, 2024
- MANGOCEUTICALS, INC. Files 8-K on Security Holder Vote Matters — 8-K · Jun 18, 2024
- MANGOCEUTICALS, INC. Files 8-K: Equity Sales & Officer Changes — 8-K · Jun 5, 2024
- Mangoceuticals Files Definitive Proxy Statement — DEF 14A · May 16, 2024
- MANGOCEUTICALS, INC. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 15, 2024
- Mangoceuticals, Inc. Files S-1/A Amendment — S-1/A · May 6, 2024
- MANGOCEUTICALS, INC. Files 8-K on Listing Standards, Rights, and Bylaws — 8-K · May 2, 2024
- MANGOCEUTICALS, INC. Files 8-K for Acquisition and Equity Events — 8-K · Apr 25, 2024
- MANGOCEUTICALS, INC. Files S-1 Registration Statement — S-1 · Apr 23, 2024
- MANGOCEUTICALS, INC. Files 8-K: Material Agreement, Equity Sales — 8-K · Apr 11, 2024
- Mangoceuticals, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Apr 1, 2024
- MANGOCEUTICALS, INC. Announces Board Changes and Compensatory Arrangements — 8-K · Mar 26, 2024
- Mangoceuticals, Inc. Schedules Special Stockholder Meeting for March 25, 2024 — DEF 14A · Mar 1, 2024
- MGRX Updates Contact Info in 8-K Filing — 8-K · Jan 25, 2024
- MANGOCEUTICALS Files 8-K on Jan 18 Event; Nasdaq Listing Confirmed — 8-K · Jan 23, 2024
- Jacob D. Cohen Amends MANGOCEUTICALS Stake, Joins Shareholder Group — SC 13D/A · Jan 2, 2024